352
Views
18
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Keratinocyte growth factor pretreatment prevents radiation-induced intestinal damage in a mouse model

, , , , &
Pages 419-426 | Received 22 Oct 2012, Accepted 22 Jan 2013, Published online: 07 Mar 2013

References

  • Hendry JH, Potten CS, Roberts NP. The gastrointestinal syndrome and mucosal clonogenic cells: relationships between target cell sensitivities, LD50 and cell survival, and their modification by antibiotics. Radiat Res 1983;96:100–12.
  • Potten CS. A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int J Radiat Biol 1990;58:925–73.
  • Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 1994;266:1253–5.
  • Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 1989;86:802–6.
  • Revest JM, Suniara RK, Kerr K, Owen JJ, Dickson C. Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J Immunol 2001;167:1954–61.
  • Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE, Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 1994;94:1764–77.
  • Pierce GF, Yanagihara D, Klopchin K, Danilenko DM, Hsu E, Kenney WC, Stimulation of all epithelial elements during skin regeneration bykeratinocyte growth factor. J Exp Med 1994;179:831–40.
  • Ulich TR, Yi ES, Cardiff R, Yin S, Bikhazi N, Biltz R, Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. Am J Pathol 1994;144:862–8.
  • Yi ES, Yin S, Harclerode DL, Bedoya A, Bikhazi NB, Housley RM, Keratinocyte growth factor induces pancreatic ductal epithelial proliferation. Am J Pathol 1994;145:80–5.
  • Yi ES, Shabaik AS, Lacey DL, Bedoya AA, Yin S, Housley RM, Keratinocyte growth factor causes proliferation of urothelium in vivo). J Urol 1995;154:1566–70.
  • Danilenko DM, Ring BD, Yanagihara D, Benson W, Wiemann B, Starnes CO, Keralinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Am J Palhol 1995;147:145–54.
  • Yang H, Wildhaber B, Tazuke Y, Teitelbaum DH. 2002 Harry M. Vars research award: Keratinocyte growth factor stimulates the recovery of epithelial structure and function in a mouse model of total parenteral nutrition. JPEN J Parenter Enteral Nutr 2002;26:333–40; discussion 340-1.
  • Yang H, Wildhaber BE, Teitelbaum DH. 2003 Harry M. Vars Research Award. Keratinocyte growth factor improves epithelial function after massive small bowel resection. JPEN J Parenter Enteral Nutr 2003;27:198–206; discussion 206-7.
  • Chen Y, Chou K, Fuchs E, Havran WL, Boismenu R. Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA 2002;99:14338–43.
  • Farrell CL, Rex KL, Kaufman SA, Dipalma CR, Chen JN, Scully S, Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice. Int J Radiat Biol 1999;75:609–20.
  • Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 1998;58:933–9.
  • Farrell CL, Rex KL, Chen JN, Bready JV, DiPalma CR, Kaufman SA, The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 2002;35:78–85.
  • Saha S, Bhanja P, Liu L, Alfieri AA, Yu D, Kandimalla ER, TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome. PLoS One 2012;7:e29357.
  • Mihaescu A, Santén S, Jeppsson B, Thorlacius H. Rho kinase signalling mediates radiation-induced inflammation and intestinal barrier dysfunction. Br J Surg 2011;98:124–31.
  • Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphologic, hemodynamic and metabolic reappraisal. Arch Surg 1970;101:478–83.
  • Smith PL. Methods for evaluating intestinal permeability and metabolism in vitro. Pharm Biotechnol 1996;8:13–34.
  • UKCCCR Anal Cancer Trial Working Party, UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: results from the KCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;19:1049–54.
  • Thomas G. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol 2000;10:44–50.
  • Zimmerer T, Bocker U, Wenz F, Singer MV. Medical prevention and treatment of acute and chronic radiation induced enteritis–is there any proven therapy? a short review. Z Gastroenterol 2008;46:441–8.
  • Hauer-Jensen M. Late radiation injury of the small intestine. Clinical, pathophysiologic and radiobiologic aspects. A review. Acta Oncol 1990;29:401–15.
  • Coia LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 1995;31:1213–36.
  • Strauman MC, Harper JM, Harrington SM, Boll EJ, Nataro JP. Enteroaggregative Escherichia coli disrupts epithelial cell tight junctions. Infect Immun 2010;78:4958–64.
  • Saha S, Bhanja P, Kabarriti R, Liu L, Alfieri AA, Guha C. Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice. PLoS One 2011;6:e24072.
  • Kahn WB, Shui C, Ning S, Knox SJ. Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Rad Res 1997;148:248–53.
  • Potten CS, Grant HK. The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. Br J Cancer 1998;78:993–1003.
  • Forstner JF, Forstner GG. Gastrointestinal mucus. In Johnson L, editor. Physiology of the gastrointestinal tract. New York: Raven; 1994. pp 1255–83.
  • Poulsom R, Wright NA. Trefoil peptides: a newly recogni/ed family of epithelial mucin-associated molecules. Am J Physiol 1993;265:G205–I3.
  • Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R, Hanby AM, Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Nati Acad Sci USA 1996;93:2137–42.
  • Mashimo H, Wu D-C, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science (Washington DC) 1996;274:262–5.
  • Samak G, Suzuki T, Bhargava A, Rao RK. c-Jun NH2-terminal kinase-2 mediates osmotic stress-induced tight junction disruption in the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 2010;299:G572–84.
  • Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol 2010;10:316.
  • Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;171:6164–72.
  • Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 2005;19:923–33.
  • Montalto M, Maggiano N, Ricci R, Curigliano V, Santoro L, Di Nicuolo F, Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells. Digestion 2004;69:225–8.
  • Parassol N, Freitas M, Thoreux K, Dalmasso G, Bourdet-Sicard R, Rampal P. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol 2005;156:256–62.
  • Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003;52:988–97.
  • Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 2007;9:804–16.
  • Liao AP, Petrof EO, Kuppireddi S, Zhao Y, Xia Y, Claud EC, Salmonella type III effector AvrA stabilizes cell tight junctions to inhibit inflammation in intestinal epithelial cells. PLoS One 2008;3:e2369.
  • Dublineau I, Lebrun F, Grison S, Griffiths NM. Functional and structural alterations of epithelial barrier properties of rat ileum following X-irradiation. Can J Physiol Pharmacol 2004;82:84–93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.